{"pmid":32357997,"title":"Coagulopathy associated with COVID-19.","text":["Coagulopathy associated with COVID-19.","CMAJ","Lee, Stephanie G","Fralick, Michael","Sholzberg, Michelle","32357997"],"journal":"CMAJ","authors":["Lee, Stephanie G","Fralick, Michael","Sholzberg, Michelle"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32357997","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1503/cmaj.200685","locations":["Coagulopathy"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138495290179584,"score":9.490897,"similar":[{"pmid":32395964,"title":"[Dealing with COVID-19-associated coagulopathy].","text":["[Dealing with COVID-19-associated coagulopathy].","COVID-19 is associated with a high prevalence of activation of the coagulation cascade. It has been suggested that this so-called COVID-19-associated coagulopathy is predictive of a poor outcome and of mortality. Consensus documents on how to manage patients with COVID-19-associated coagulopathy are based on the limited number of mainly retrospective studies that is currently available, and for this reason the recommendations are not always consistent with one another. In this article, we review the first studies into COVID-19-associated coagulopathy and give the most important do's and don'ts for diagnostics and the daily management of coagulopathy and the prevention of complications in patients with, or with strongly-suspected, COVID-19 in Dutch clinical practice.","Ned Tijdschr Geneeskd","Klok, Frederikus A","den Exter, Paul L","Huisman, Menno V","Eikenboom, Jeroen","32395964"],"abstract":["COVID-19 is associated with a high prevalence of activation of the coagulation cascade. It has been suggested that this so-called COVID-19-associated coagulopathy is predictive of a poor outcome and of mortality. Consensus documents on how to manage patients with COVID-19-associated coagulopathy are based on the limited number of mainly retrospective studies that is currently available, and for this reason the recommendations are not always consistent with one another. In this article, we review the first studies into COVID-19-associated coagulopathy and give the most important do's and don'ts for diagnostics and the daily management of coagulopathy and the prevention of complications in patients with, or with strongly-suspected, COVID-19 in Dutch clinical practice."],"journal":"Ned Tijdschr Geneeskd","authors":["Klok, Frederikus A","den Exter, Paul L","Huisman, Menno V","Eikenboom, Jeroen"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32395964","source":"PubMed","week":"202020|May 11 - May 17","locations":["coagulopathy","Dutch"],"countries":["Netherlands"],"countries_codes":["NLD|Netherlands"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666627827905069057,"score":41.2182},{"pmid":32409435,"title":"Coagulopathy in COVID-19.","text":["Coagulopathy in COVID-19.","COVID-19-associated coagulopathy is common in patients with COVID-19, causing high rates of thrombotic complications that increase the morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings and correlate with severity of illness and risk of thrombosis. Aggressive VTE prophylaxis is paramount for all patients with COVID-19. Patients with very high D-dimer levels (6 times the upper limit of normal, greater than 3,000 ng/mL) have the greatest risk of thrombosis and may benefit from active screening and more intensive VTE prophylaxis.","Cleve Clin J Med","Mucha, Simon R","Dugar, Siddharth","McCrae, Keith","Joseph, Douglas E","Bartholomew, John","Sacha, Gretchen","Militello, Michael","32409435"],"abstract":["COVID-19-associated coagulopathy is common in patients with COVID-19, causing high rates of thrombotic complications that increase the morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings and correlate with severity of illness and risk of thrombosis. Aggressive VTE prophylaxis is paramount for all patients with COVID-19. Patients with very high D-dimer levels (6 times the upper limit of normal, greater than 3,000 ng/mL) have the greatest risk of thrombosis and may benefit from active screening and more intensive VTE prophylaxis."],"journal":"Cleve Clin J Med","authors":["Mucha, Simon R","Dugar, Siddharth","McCrae, Keith","Joseph, Douglas E","Bartholomew, John","Sacha, Gretchen","Militello, Michael"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409435","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3949/ccjm.87a.ccc024","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666897319169097729,"score":41.2182}]}